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Abstract
Introduction: The acute respiratory distress syndrome (ARDS), affects up to 150,000 patients per year in the United
States. We and other groups have demonstrated that bone marrow derived mesenchymal stromal stem cells
prevent ARDS induced by systemic and local administration of endotoxin (lipopolysaccharide (LPS)) in mice.
Methods: A study was undertaken to determine the effects of the diverse populations of bone marrow derived
cells on the pathophysiology of ARDS, using a unique ex-vivo swine preparation, in which only the ventilated lung
and the liver are perfused with autologous blood. Six experimental groups were designated as: 1) endotoxin alone,
2) endotoxin + total fresh whole bone marrow nuclear cells (BMC), 3) endotoxin + non-hematopoietic bone
marrow cells (CD45 neg), 4) endotoxin + hematopoietic bone marrow cells (CD45 positive), 5) endotoxin + buffy
coat and 6) endotoxin + in vitro expanded swine CD45 negative adherent allogeneic bone marrow cells (cultured
CD45neg). We measured at different levels the biological consequences of the infusion of the different subsets of
cells. The measured parameters were: pulmonary vascular resistance (PVR), gas exchange (PO2), lung edema (lung
wet/dry weight), gene expression and serum concentrations of the pro-inflammatory cytokines IL-1b, TNF-a and IL-
6.
Results: Infusion of freshly purified autologous total BMCs, as well as non-hematopoietic CD45(-) bone marrow
cells significantly reduced endotoxin-induced pulmonary hypertension and hypoxemia and reduced the lung
edema. Also, in the groups that received BMCs and cultured CD45neg we observed a decrease in the levels of IL-
1b and TNF-a in plasma. Infusion of hematopoietic CD45(+) bone marrow cells or peripheral blood buffy coat cells
did not protect against LPS-induced lung injury.
Conclusions: We conclude that infusion of freshly isolated autologous whole bone marrow cells and the subset of
non-hematopoietic cells can suppress the acute humoral and physiologic responses induced by endotoxemia by
modulating the inflammatory response, mechanisms that do not involve engraftment or trans-differentiation of the
cells. These observations may have important implications for the design of future cell therapies for ARDS.
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Introduction
Respiratory diseases kill more than 400,000 Americans
each year and significantly reduce the quality of life for
millions more. The National Heart, Lung and Blood
Institute (NHLBI) estimated that in 2009 the annual
cost of providing healthcare related to all respiratory
conditions, excluding lung cancer, was $113 billion [1].
Acute Respiratory Distress Syndrome (ARDS) is a very
common clinical entity and a major cause of morbidity
and mortality in the critical care setting. Historically,
ARDS has been associated with mortality ranging from
40% to 60%, with worse outcomes in the older popula-
tion. In the US alone, 150,000 new cases of ARDS occur
every year [2]. Moreover, ARDS has a significant impact
on long-term disability and adverse psycho-social out-
comes in survivors [3]. According to the Berlin defini-
tion of ARDS, the diagnostic criteria for ARDS rely on
four categories: (i) timing: within one week of a known
clinical insult or new or worsening respiratory symp-
toms; (ii) radiographic: bilateral opacities not fully
explained by effusions, lobar/lung collapse, or nodule;
(iii) origin of lung edema: respiratory failure not fully
explained by cardiac failure or fluid overload; and (iv)
oxygenation impairment. Consequently, ARDS was
divided into three categories according to the degree of
hypoxemia: mild, moderate and severe. Thus, the Berlin
definition eliminated the concept of acute lung injury
(ALI), which now falls into the category of mild ARDS.
ARDS always results from another severe underlying
disease. The range of diseases causing ARDS is broad,
and they may also damage organs other than the lungs,
but the lung injury invariably dominates the clinical pic-
ture. Sepsis is the most common condition leading to
ARDS. In mammals, ARDS is initiated by an acute
inflammatory response to a physical trauma or infection
[4-9] followed by sequestration of neutrophils in the
lung, lung edema, and up-regulation of inflammatory
mediators both locally and systemically.
Bone marrow derived stem cells can be divided in two
groups: hematopoietic stem cells (HSC) and mesenchy-
mal stromal stem cells (MSC). Bone marrow derived
MSC were first described in the early 1970s by Frieden-
stein and collaborators [10-13]. They are defined as clo-
nal, plastic adherent cells capable of differentiating into
cells of mesenchymal origin. These cells are also able to
support hematopoiesis in culture providing extracellular
matrix, cytokines, and growth factors to the HSC. The
ultimate characterization of mesenchymal stem cells has
been a complicated issue since there are no specific cell
surface markers. Enrichment of mesenchymal stem cells
from crude bone marrow suspensions is achieved by
selecting a plastic-adherent population that expresses
neither hematopoietic nor endothelial cell surface
markers but is positive for the expression of adhesion
and stromal markers [14]. The criterion for establishing
MSC phenotype is to use adherent cells that: (i) express
CD44, CD73, CD90 and CD105; (ii) lack the expression
of hematopoietic markers, such as CD45, CD34 and
CD31; and (iii) confirm their plasticity by the ability of
the cells to differentiate into adipocytes, osteocytes, and
chondrocytes in a multilineage differentiation assay [15].
Cells used in the present work are non-hematopoietic
bone marrow adherent cells. However, because the cells
were not completely characterized, mainly because of
the lack of specific antibodies to all the markers
required, we limit the denomination to in vitro
expanded swine CD45 negative adherent allogeneic
bone marrow cells (cultured CD45neg)
Cell-based therapy in experimental models of ARDS
and sepsis has been the focus of intense investigation
since the publication of our original work in 2007 [16].
In our initial observation, we defined the beneficial
effects of the systemic administration of mesenchymal
stem cells to control ARDS mainly by their anti-inflam-
matory properties. Multiple groups have reported simi-
lar observations where the protective effect has been
demonstrated in different animal models and human ex-
vivo lungs [17-22]. The protective effects of mesenchy-
mal stem cells are attributed to several mechanisms
including secretion of the anti-inflammatory cytokines
IL-10 and TGF-b, and Keratinocyte Growth Factor
(KGF) and elaboration of antibacterial peptides. As a
result of these most recent studies, mesenchymal stem
cells are increasingly recognized for having complex
interactions with the host immune system and share
properties with cells of the innate immune system.
Given the pleiotropic effects of these stem cells in the
setting of ARDS and sepsis, there has been considerable
interest in initiating translational studies in this field.
In the present pre-clinical model, we found that infu-
sion of freshly purified autologous nuclear bone marrow
cell preparations or non-hematopoietic CD45 (-) bone
marrow cells has similar protective characteristics to in
vitro expanded CD45neg by moderating the very early
pathophysiological events in endotoxin-induced lung
injury. They also were able to moderate pulmonary
hypertension and hypoxemia and, in the case of bone
marrow cells and cultured CD45neg, attenuated the
increase in serum levels of the pro-inflammatory cyto-
kines TNF-a and IL-1b.Neither autologous buffy coat
cells nor hematopoietic CD45 (+) cells had those effects.
We conclude that similar to cultured CD45neg, freshly
isolated nucleated bone marrow cells and the subpopula-
tion of non-hematopoietic bone marrow cells can interact
with the immune system to modulate inflammation and
control lung injury resulting from severe endotoxemia.
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Methods
The in situ piglet preparation
We have previously described an ex-vivo perfusing piglet
preparation, which permits perfusion restricted to the
lung and the liver using autologous blood [23]. Piglets
were anesthetized, a tracheostomy was performed, and
cannulas were placed in a carotid artery and a jugular
vein. After heparinization, the animals were ex-sangui-
nated and the blood was used to fill the blood reservoir
and the perfusion circuit. The lungs were perfused at a
constant flow rate of 40 ml/kg/minute (up to 400 ml/
min); half of the blood in the efferent circuit transverses
the liver before perfusing the lung. In all the preparations,
lungs were ventilated under the same conditions with a
piston ventilator (Harvard Apparatus, Dover, MA, USA)
with room air and 5% CO2. The minute ventilation was
adjusted to maintain perfusate pH between 7.35 and 7.45.
Throughout the experiments, pressures in the pulmonary
artery, left atrium and portal vein and flow in and out of
both organs was monitored continuously and the data
were stored in a computer for later analysis.
The study adhered to National Institute of Health
guidelines on the use of experimental animals and was
approved by the institutional animal care and use com-
mittee of Emory University. Animals were maintained in
the Emory University Division of Animal Resources, an
AAALAC approved facility.
Experimental protocols and data collection
Six groups of experiments were performed with four to
six animals in each group. The groups were designated
as: 1) endotoxin alone, 2) endotoxin + freshly isolated
autologous bone marrow nuclear cells, 3) endotoxin +
non-hematopoietic bone marrow autologous cells CD45
(-), 4) endotoxin + hematopoietic bone marrow cells
CD45(+), 5) endotoxin + buffy coat and 6) endotoxin +
in vitro expanded swine CD45 negative adherent allo-
geneic bone marrow cells (cultured CD45neg). For all
the groups, 5 μg/kg body weight of endotoxin was used
(Serotype O55:B5 Difco, Detroit, MI, USA), directly into
the blood reservoir fifteen minutes after endotoxin cells
were added to the blood reservoir. A total of 100 x106
whole bone marrow cells were used. In the case of the
subpopulations, CD45 (-), CD45(+), buffy coat and cul-
tured CD45neg, 50 x106 purified cells were perfused in
each preparation. Blood samples were collected before
and after endotoxin administration. Blood gas analysis
was performed every 15 minutes for the duration of the
experiment using a portable blood gas analyzer (Rapi-
dlab 248, Diamond Diagnostics, East Walpole, MA,
USA). Serum samples were separated and stored at -80o
for measurement of TNF-a, IL-6 and IL-1b. Automated
cell count and differential counts were performed every
15 minutes using a device which is specifically designed
for use in laboratory animals (Hemevet, CDC Technolo-
gies, Oxford, CT, USA). At each time point, we
recorded pressures and flows in and out of the lungs
and flow to the liver. Pulmonary vascular resistance
(PVR) was calculated as in-flow pressure (pulmonary
artery pressure) minus out-flow pressures (left atrial
pressure) divided by total blood flow through the lungs
and expressed in cm H2O/ml/min. Temperature was
measured continuously and kept between 38°C and 40°C
by adjusting the temperature of the water in the water-
jacket surrounding the reservoir.
Lung and liver tissue specimens were obtained at
three time points (30 minutes before endotoxin and 45
minutes and 135 minutes after endotoxin) for the deter-
mination of histology, cell engraftment and gene expres-
sion in a microarray system. The study was terminated
two and a half hours after endotoxin administration and
both lungs were taken for determination of wet-to-dry
weight ratio.
Generation and administration of cells
Briefly, fresh swine bone marrow derived cells were iso-
lated by mechanically extracting bone marrow from
both femurs of the animal while the preparation was
being set up. The harvested bone marrow was cut in
small fragments and cells detached by continuous vortex
for 30 seconds followed by 1X trypsin-ethylenediamine-
tetraacetic acid (EDTA) for 2 minutes. Cell suspensions
were centrifuged for 2 minutes at 700 RPM to separate
insoluble material. Supernatant was collected and cells
transferred to a 50 ml conical tube where cells were
washed twice with PBS containing penicillin-streptomy-
cin. Red blood cells were lysed by re-suspending the cell
pellet with 3 ml of sterile water. After 15 seconds lysis
was stopped by adding 27 ml of 10X PBS for a final
concentration of 1X PBS. Cells were washed twice with
sterile PBS and counted in a hemocytometer. To isolate
CD45 (+) and CD45 (-) cells, 300 × 106 bone marrow
cells were transferred into a 15 ml conical tube and
incubated with 35 μg of fluorescein isothiocyanate
(FITC) conjugated mouse anti-porcine CD45 (ABD Ser-
otec, Oxford, UK) for 10 minutes at 4#176;C. Cells were
washed twice with cold MACS buffer (PBS +0.5% BSA
+2mM EDTA). After washing, cells were re-suspended
in 1.5 ml MACS buffer and incubated with 300 μl of
anti-FITC microbeads (Myltenyi Biotec, Auburn, CA,
USA) for 15 minutes at 4#176;C. CD45 (-) cells were
sorted using LD columns (Myltenyi Biotec, Auburn, CA,
USA). Cell sorting was repeated once to ensure the pur-
ity of the cells. Cells that were retained in the column
were used as CD45 (+) cells. After the final elution, cells
were washed twice with sterile saline solution. Before
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infusion, cells were counted in a hemocytometer with
Trypan blue to determine cell numbers and viability.
Autologous buffy coat cells were obtained by separat-
ing leukocytes from fresh heparinized peripheral blood
by osmotic gradient using HISTOPAQUE® 1083 (Sigma,
St Louis, MO, USA). Twenty ml of fresh blood was cen-
trifuged and red blood cells lysed. Cells were re-sus-
pended in 20 ml of PBS and placed on top of 20 ml of
Histopaque 1083. The opaque interface, containing the
mononuclear cell band, was collected using a Pasteur
pipet and transferred into a 50 ml conical centrifuge
tube. Cells were washed twice with PBS. After the last
wash, cells were counted to determine viability and cell
numbers.
Swine CD45 negative adherent allogeneic bone marrow
cells (cultured CD45neg) were isolated by negative selec-
tion of CD45(+) cells, using an anti-CD45-FITC antibody,
followed by anti-FITC-conjugated magnetic beads (Milte-
nyi Biotec). Cultured CD45neg cells were expanded in
vitro in 175 cm2 flasks in Iscove’s modified Dulbeccos’s
medium (IMDM) containing 9% fetal bovine serum (FBS,
Atlanta, Biologicals, Norcross, GA, USA), 9% horse
serum, and 1% penicillin-streptomycin. Cells were har-
vested at 70% confluence using 0.25% trypsin. For in vivo
infusion, cells were detached using 0.25% trypsin at 37°C
for 5 minutes. Trypsin was neutralized by adding IMDM
with 10% serum. The cell suspension was centrifuged and
suspended in sterile PBS (without Ca and Mg). After two
additional washes with PBS, cells were counted in a
hemocytometer with trypan blue and were re-suspended
in PBS at 5 × 106 cells per ml final concentration.
To track the cells in the swine preparation, BMCs
were surface-labeled using PKH (Sigma. St Louis MO,
USA). Prior to infusion, 10 × 107 cells were re-sus-
pended in 5 ml of staining buffer and 50 μl of PKH
solution were added. After incubating for 5 minutes at
room temperature, the reaction was stopped by adding
10 ml of complete FBS. Cells were washed twice with 50
ml of sterile saline solution. Before infusion, cells were
counted to determine viability and cell numbers.
FACS analysis
Blood samples obtained from preparations were col-
lected at different time points. Red blood cells were
lysed by hypotonic shock and samples analyzed for
PKH-26 staining on a fluorescence-assisted cell sorting
(FACS) Excalibur (Becton Dickinson, San Jose, CA,
USA), using CellQuest software (Becton Dickinson, San
Jose, CA, USA) and analyzed using FlowJo software
(Tree Star, San Carlos, CA, USA).
Immunohistochemistry
Pig lungs were placed in 2% paraformaldehyde and pro-
cessed for paraffin embedding. Sections (5 mm) were cut,
mounted on the slides, and subjected to antigen retrieval
in a decloaking chamber (BioCare Medical, Gaithersburg,
MD, USA). Endogenous peroxidase activity was quenched
with 3% peroxide for 5 minutes. Slides were incubated
with anti-myeloperoxidase antibody (MPO) (Abcam
Cambridge, MA, USA) overnight at 4#176;C. Immune
complexes were visualized with biotinylated secondary
antibody and 3,3’-diaminobenzidine tetrahydrochloride
using the streptavidin-biotin complex method.
Cytokine measurements
Plasma concentrations of TNF-a, IL-6 and IL-1b were
measured separately using Quantikine® ELISA kits
(R&D Systems, Minneapolis, MN, USA) according to
the manufacturer’s instructions. Briefly, samples were
dispensed into 96-well micro-titer plates that are pre-
coated with porcine monoclonal or polyclonal antibodies
specific to the above cytokines. After washing away any
unbound substances, an enzyme (horseradish peroxi-
dase)-linked monoclonal (TNF-a) or polyclonal (IL-6
and IL-1b) antibody specific to the above cytokines was
added to the wells. Following a wash to remove any
unbound antibody-enzyme reagent, a substrate solution
(hydrogen peroxide/tetramethylbenzidine) was added to
the wells. The reaction was terminated with a stop buf-
fer and absorbance read at 450 nm using an MRX Reve-
lation (Dynex Technologies, Chantilly, VA, USA) multi-
well plate reader. Values of IL-6, TNF-a and IL-1b were
determined by reference to a standard curve constructed
using the porcine proteins and computer software cap-
able of generating a four parameter logistic curve-fit.
Measurements of lung water
At the completion of each experiment, both lungs were
harvested and homogenized. The homogenate was
weighed (wet weight), then dried to constant weight in a
microwave oven and reweighed (dry weight). The ratio
of wet/dry lung weight was calculated as a measure of
the amount of lung water (edema) that was present.
Liver RNA isolation and Affymetrix GeneChip array
We used a swine specific microarray chip from Affyme-
trix with 27,000 genes represented. RNA was isolated
from liver tissue samples taken 30 minutes after endo-
toxin in a liver-lung perfused preparation or after 30
minutes of perfusion without addition of endotoxin as a
control. We performed microarray analyses of these
samples and calculated the ratio of expression in the
sample from the endotoxin-treated preparation to the
control sample. Liver tissue samples from both endo-
toxin and endotoxin-bone marrow cell groups were
homogenized in TRIzol reagent (Gibco BRL, Gaithers-
burg, MD, USA), and RNA was extracted according to
the instructions of the manufacturer. RNA precipitates
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were briefly air-dried then subjected to an RNeasy pro-
tect mini kit and DNAse I treatment (Qiagen, Miami,
FL, USA). Total RNA concentration was measured spec-
trophotometrically at 260 and 280 nm and dissolved in
RNAse-free water to 1 µg/µL and stored at -80°C. For
control of concentration and integrity, 1 µg of each
RNA sample was subjected to formaldehyde-agarose
electrophoresis.
Total RNA (5 µg) was used for microarray analysis on
swine Affymetrix chips. Preparation of complementary
RNA, hybridization, scanning and image analysis of the
microarrays were each performed according to the man-
ufacturer’s protocol (Affymetrix, Santa Clara, CA, USA)
at the Emory Bio-Core facility with a final ArrayExpress
accession: E-MTAB-1436
Statistical analysis
Statistically significant differences were determined by
using analysis of variance (ANOVA) and Tukey-Kramer
for post hoc test. P <0.05 was considered significant. In
most cases the physiological data are presented as
change from baseline, with the baseline calculated as the
mean of values at thirty minutes prior and immediately
prior to administering endotoxin.
Results
Infusion of autologous bone marrow cells prevented lung
inflammation induced by systemic administration of
endotoxin
As one measure of the inflammatory response, we ana-
lyzed the influx of neutrophils into lungs by MPO
immunostaining of histologic sections. As shown in
Figure 1, lungs from animals receiving endotoxin had
extensive infiltration of MPO-positive cells, most promi-
nently at 45 minutes after administering endotoxin [23].
The marked alteration in lung architecture was largely
resolved by 135 min after endotoxin. To investigate
whether infusion of freshly isolated total BMCs into the
Endo 2 
Endo 1 
BMCs 1 
BMCs 2 
BMCs 3 
15 min 45 min 135 min A. 
B. 
Figure 1 Systemic administration of freshly isolated autologous whole bone marrow nuclear cells (BMC) modifies endotoxin (LPS)
induced lung inflammation. A. Lung biopsies were obtained at the indicated time points after endotoxin and stained with an anti-
myeloperoxidase (MPO) antibody to detect neutrophils. Samples from two independent animals treated with endotoxin (Endo1 and 2) are
shown. Note the significant alteration of lung architecture with increased inflammatory infiltrates and edema at 15 and 45 minutes after
endotoxin. B. Histological lung sections stained with MPO from swine preparations infused with total BMCs 15 minutes after endotoxin. Three
independent animals are shown (BMC 1, 2 and 3). Tissue samples were collected at the indicated time points after endotoxin. Notice reduction
in the severity of inflammation and edema compared to endotoxin alone treated swine. LPS, lipopolysaccharide.
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lung reduced the lung inflammatory response, we added
100 × 106 cells of fresh isolated autologous BMCs to the
reservoir 15 minutes after endotoxin. Histopathological
analyses and MPO staining of lungs treated with BMCs
showed reduced inflammatory infiltrates and tissue
edema at the 45-minute time point (Figure 1) compared
to animals receiving endotoxin alone.
Trafficking of infused bone marrow cells in the lung after
endotoxin-induced lung injury
To determine the homing of whole bone marrow cells
to the lung in response to endotoxin, BMCs were
labeled with a fluorescent membrane dye, PKH26. Fif-
teen minutes after adding endotoxin to the reservoir,
100 × 106 labeled cells were added to the reservoir and
the cell traffic was followed by collecting 0.5 ml blood
samples from the pulmonary vein and pulmonary artery
every 5 minutes until the end of the experiment. We
detected few PKH labeled cells in histological sections
from lungs (Figure 2A); however, a substantial number
of labeled cells were detected by FACS analysis in the
peripheral blood. Figure 2B shows higher numbers of
labeled cells in afferent than in efferent circulation of
the lungs during the early time points which is consis-
tent with the retention of the cells in the lung after
injury that has been observed in other animal models.
BMCs infusion protects against endotoxin-induced
pulmonary hypertension and hypoxemia
Figure 3A shows attenuation of endotoxin-induced pul-
monary hypertension by the infusion of freshly isolated
autologous BMCs. Similarly, statistically significant
diminution of the pulmonary vascular resistance
response to endotoxin was observed when the subpopu-
lations of non-hematopoietic CD45(-) bone marrow
cells or swine CD45 negative adherent allogeneic bone
marrow cells (cultured CD45neg) were administered.
Neither buffy coat nor hematopoietic CD45(+) cells
affected the endotoxin-induced pulmonary hypertension
significantly (Figure 3B).
Systemic administration of endotoxin also resulted in
arterial hypoxemia. Those values are shown over the
course of the endotoxin reaction in Figure 4. Arterial
hypoxemia following endotoxin was attenuated signifi-
cantly by administration of either total autologous
BMCs, non-hematopoietic CD45(-) cells or swine cul-
tured CD45neg cells. Some average effect was also seen
with either buffy coat or CD45 (+) cells, but these were
not significantly different from endotoxin alone.
Infusion of fresh autologous BMC decreased
endotoxemia-induced lung edema
As we have reported previously, endotoxin causes a
large and significant increase in lung water content
[24-30]. Lung wet to dry weight ratios in the experi-
ments reported here are shown in Figure 5. For refer-
ence, as has been published by our group, average
values in control experiments are approximately 7 [23].
Endotoxin caused pulmonary edema that was signifi-
cantly attenuated by the infusion of autologous BMCs
and swine cultured CD45neg. The lung wet-to-dry
weight ratios were not significantly different from the
endotoxin group in groups receiving either the subpopu-
lations of CD45(+), CD45(-) or buffy coat.
Modification of gene expression in the liver by infusion
of bone marrow cells
Since previous studies showed that maximal activation of
lung pro-inflammatory responses required the presence of
the liver, we analyzed gene expression in liver samples
after administration of endotoxin. Table 1 lists all of the
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Figure 2 Infused autologous bone marrow nuclear cells are
retained in the lungs after endotoxin-induced acute lung
injury. To differentiate infused from endogenous cells, isolated cells
were surface stained with PKH. To detected engrafted cells in the
lung, a sample of lung tissue was collected at the end of the
experiment and frozen in Tissue-Tek solution. A. Persistent
localization of PKH staining bone marrow cells (red) in the lung
following endotoxemia in the swine liver-lung perfused preparation
(blue = nuclei). B. To demonstrate trapping of the cells in the lung,
0.5 cc blood sample was collected every 5 minutes from the
pulmonary vein and artery, and analyzed by FACS. On B, there is a
quantification of the percentage of PKH+ cells collected from blood
before and after the lung. FACS, fluorescence-assisted cell sorting.
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identified genes that were at least two fold higher in the
post endotoxin sample than in samples from animals that
did not receive endotoxin. Potential candidate mediators
of liver-dependent lung injury are highlighted in the table.
Analysis of the data using the Integrity Systems software
which links gene expression patterns to biologic pathways,
showed the major association with immune/inflammation
pathways. Interestingly, of the genes expression of which
was increased by endotoxin, 20 were identified as belong-
ing to the canonical acute phase response pathway.
Figure 6 shows the effects of BMCs on endotoxin-
induced hepatic gene expression, both the fold effect
(that is, the ratio of expression with BMCs and endo-
toxin to expression with endotoxin alone) and the net-
work analysis of gene expression. These results of gene
expression implicate IL-1b and TNF-a as prime candi-
dates for the liver-induced lung injury seen after endo-
toxin. To confirm these results we measured levels of
these two cytokines, together with IL-6 as the other
inflammatory cytokine involved on ARDS, in the perfu-
sate at baseline and at 15-minute intervals following
endotoxin administration and infusion of autologus
BMCs, buffy coat and swine cultured CD45neg cells
(Figure 7). Endotoxin induced progressive increases in
all three cytokines, with particularly high levels of TNF-
a. Total BMCs significantly attenuated the TNF-a and
IL-1b responses whereas expanded cultured CD45neg
cells mainly diminished IL-1b levels. Buffy coat cells had
no effect on any of these pro-inflammatory responses.
Levels of IL-6 were not affected significantly by the infu-
sion of any type of cell.
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Figure 3 Freshly isolated bone marrow nuclear cells moderated the increase in pulmonary vascular resistance induced by endotoxin.
A. Comparison of effects of the fresh bone marrow cells and the blood buffy coat cells on the pulmonary vascular resistance response. B.
Endotoxin-induced PVR rapidly recovered in preparations in which CD45(-) and cultured CD45neg cells were included but persisted in the
presence of CD45(+). (n = 6 in each group, **P <0.01). PVR, pulmonary vascular resistance.
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Figure 4 Changes of blood oxygenation are abrogated by the
infusion of bone marrow derived cells. A. Change from baseline
perfusate oxygen tension expressed in mmHg (means ± SE) in six
experimental groups over the two-hour experimental period.
Perfusate blood pO2 was measured with a blood gas analyzer. From
the infused cell, buffy coat and CD45(+) have the weakest
protective effect compared to total BMCs and cultured CD45neg
cells. Statistical analysis was done by 2-way ANOVA and Tukey-
Kramer for post hoc test. ANOVA, analysis of variance.
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Discussion
One reason for the high morbidity and mortality of
ARDS is the lack of effective treatment available. Cur-
rently, the only existing therapy is limited to supportive
care. Since the introduction of ventilation with low tidal
volumes there has been a significant decrease in mortal-
ity and an increase in the number of days without venti-
lator use, which often results in further injury to the
lungs [31]. Peak end-expiratory pressure (PEEP) is also
an essential component of mechanical ventilation that
decreases repetitive opening and closing during the
respiratory cycle and opens collapsed alveoli decreasing
intrapulmonary shunt. Other ventilatory strategies used
in ARDS include recruitment maneuvers, prone position
and high frequency ventilation, although the role of
these strategies is not well defined and improvement in
mortality has not been demonstrated [31].
ARDS can be associated with different clinical disor-
ders directly affecting the lungs (pneumonia or pulmon-
ary contusion) or systemic diseases affecting the lung
through the bloodstream (sepsis, severe trauma or acute
pancreatitis). Regardless of the cause of ARDS, the
alveolar epithelium and capillary endothelium are
affected, leading to an increase in permeability that
allows fluid to accumulate in the alveolar space (alveolar
edema). Loss of epithelial integrity also disrupts alveolar
clearance and production of surfactant [32-34]. The
extensive alveolar and endothelial damage causes an
influx of circulating inflammatory cells that secrete pro-
inflammatory cytokines such as TNF-a, IL-1b and IL-6.
A novel ex-vivo swine model developed by our group
permits the measurement of lung pathophysiology and
the simultaneous collection of lung and liver tissue for
histologic and molecular comparisons during the early
phase of the response to endotoxemia. In this prepara-
tion, endotoxemia causes a liver-dependent inflamma-
tory response and severe lung injury and dysfunction
[23]. We chose swine as an experimental animal
because, like humans, they are especially sensitive to
endotoxin and the pathophysiology of the response
appears to be similar to that in humans. The model has
some limitations as does any acute model, where the
physiology can be monitored only for a short period of
time before there is a deterioration of the organs.
Here, we find that infusion of freshly isolated suspen-
sions of autologous whole bone marrow nuclear cells,
the subpopulation of non-hematopoietic bone marrow
cells CD45(-) or in vitro expanded adherent swine
CD45neg cells, have a moderating effect on the response
to endotoxemia. As we expected, the greatest effects
were seen with swine cultured CD45neg cells. We and,
later, other groups, reported findings in mice that are
consistent with the observations that we report here
[3,16,35-37]. The ability of the infusion of bone marrow
mononuclear cells to prevent organ injury is well known
including in the lung [38,39]. In a recent publication,
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Figure 5 Infusion of BMC reduces pulmonary edema induced by systemic administration of endotoxin. As a control lung fibroblasts and
buffy coat were added instead of BMC. CD45 (-) cells significantly reduced but did not prevent pulmonary edema induced by endotoxin (n = 4
to 5 in each group, P <0.05. **). BMC, bone marrow nuclear cells.
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bone marrow derived nuclear cells were used to prevent
chronic obstructive pulmonary disease/pulmonary
emphysema in rats [40]. A similar rationale has been
used to design a clinical trial for emphysema [41]. The
present work, to our knowledge, is the first evidence in
a clinically relevant lung injury model in a large animal
preparation suggesting that freshly isolated autologous
bone marrow nuclear cells might have a possible role in
therapies for patients with acute lung injury.
The effects we observed as a consequence of cell infu-
sion are on the very early endotoxin response and do not
appear to require transdifferentiation into a lung-type cell.
These effects were accompanied by an increase in the
endotoxin-induced expression of genes encoding anti-
inflammatory cytokines and decreased endotoxin-induced
Table 1 Hepatic gene expression 30 minutes after
endotoxemia normalized to control (no endotoxin).
Encoded protein Fold Increa
se after LPS
MHC class II 62
Serine protease inhibitor 19
MHC class I 16
AMCF-1 14
Tumor necrosis factor (TNF) 14
Prointerleukin-1 beta (IL1B) 11
Lysozyme (LYZ) Hydroxymethylgluatryl-CoA 6
Synthase (HMGCS2) 5
T cell receptor alpha chain (TCR-a) 5
Interleukin-6 (IL6) 4
Interleukin-1alpha (IL1A) 4
Chemokine ligand 2 (CXCL2) 4
T cell receptor beta (TCR-b) 4
20-beta-hydroxysteroid dehydrogenase (CBR1) 3
C-JUN protein (C-JUN) 3
MHC class II SLA-DRB-c 3
Complement C7 (C7) 3
Heparin binding protein 61 3
Glutathione S-transferase (GST) 3
Prostaglandin G/H synthase-2 (PGHS-2) 3
RANTES protein (RANTES) 3
MIP-1 beta protein (MIP-1BETA) 3
Antimicrobial protein hepcidin(HAMP) 3
Interleukin-1 beta converting Enzyme (CASP1) 3
Killer cell lectin-like receptor(KLRK1) 3
CD45 antigen isoform 1 precursor (CD45) 2
Endothelin (EDN) 2
Macrophage inflammatory protein 1 alpha (CCL3) 2
Tissue factor 2
TcR gamma chain 2
Plasminogen activator (PLAU) 2
Complement C1qA (C1QA) 2
Heat shock protein 70.2 (HSP70.2) 2
Neuron-derived orphan receptor alpha (NOR-1) 2
Chemokine C-C motifreceptor 5 (CCR5) 2
Complement C1qB (C1QB) 2
SLA-DQ beta1 domanin 2
Beta-2 microglobulin (B2M) 2
TACSTD1 2
CD8 antigen alpha polypeptide (CD8A) 2
Transcription factor PU.1 (PU.1) 2
NF-k gene enhancer inhibitor (NFKBIA) 2
Identified genes with expression increased 2-fold or more; some potential
circulating mediators of lung injury are in italics.
Up-regulation                 Down-regulation 
Figure 6 Immune/inflammation network of genes in the liver
whose expression was altered by the infusion of bone marrow
derived cells were analyzed using Ingenuity Software. Response
to endotoxin in the presence of bone marrow cells relative to
responses to endotoxin alone. Red = marked increase, Pink =
increase, Green = decrease. Numbers are fold difference from the
endotoxin only control sample.
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expression of genes encoding several pro-inflammatory
cytokines in the liver compared to the effects of endotoxin
at thirty minutes after endotoxemia. An analysis of the
involved cytokine networks indicated that the principal
effects of bone marrow cells on the endotoxin molecular
response in the liver were on networks in which TNF-a
and IL1-b play pivotal roles.
A transient inflammatory response is critical to the
body’s defense against infectious and other toxic
insults. Injury of the lungs and other organs conse-
quent to sepsis in humans and several other animal
species appears to result from a dysregulated inflam-
matory response so that intense inflammation is gener-
alized and persistent [24,42,43]. In cell therapy, several
factors appear to contribute to the termination of acute
inflammation, including generation of anti-inflamma-
tory cytokines (for example, IL-10) [44-46], cytokine
inhibitors [47], antibacterial peptides [48] and growth
factors that induce protection of the alveolar epithelial
cells [49-51].
In swine, endotoxemia results in increased circulating
concentrations of several cytokines and growth factors
[23]. Although administration of bone marrow cells did
not entirely prevent these responses, they changed the
pattern of cytokine responses, significantly decreasing
generation of Th1 pro-inflammatory cytokines without
decreasing the anti-inflammatory Th2 cytokine IL-6,
preventing lung tissue responses to endotoxemia and
lung edema. Those responses were temporally coinci-
dent with decreased circulating levels of pro-inflamma-
tory cytokines (TNF-a and IL-1b) that are known to
affect inflammatory cell trafficking.
Conclusions
In summary, results presented in the present work sug-
gest that fresh, autologous non-cultured bone marrow
nuclear cells, including non-hematopoietic bone marrow
derived cells, have the ability to suppress the endotoxin-
induced systemic inflammatory response at similar
levels to what is observed when in vitro expanded
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Figure 7 Administration of freshly isolated whole bone marrow nuclear cells (BMC) altered the systemic inflammatory response to
endotoxin. Compared to responses with buffy coat cells, sixty minutes after infusion of BMC, there was a significant suppression in endotoxin-
induced increased systemic concentrations of pro-inflammatory cytokines (A) IL-1b and (B) TNF-a. There was no attenuation of endotoxin
induced release of IL-6 by any of the cells administrated (C). (n = 6 in each group, **P <0.01, *P <0.05).
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heterologous mesenchymal stromal cells are used.
Expanded or freshly isolated autologous bone marrow
mononuclear cells could prove to be a novel approach
to therapy for some acute and chronic lung diseases.
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